MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-15-0003439
Sloventis Pharma Private Limited
Sloventis Pharma Private Limited - pharma in Nadia, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹72.66 Lakh
▲ 11% YoY
Net profit · FY 2024
₹1 Lakh
Net margin 1.4%
EBITDA · FY 2024
₹2.34 Lakh
EBITDA margin 3.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹23.13 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
14
Provident fund records
About Sloventis Pharma Private Limited
Data last updated:
Sloventis Pharma Private Limited is a private limited company based in Nadia, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24290WB2020PTC237341. Its GSTIN is 21ABDCS7312J1ZJ (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Subhasmita Panda and Anil Kumar Panda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.4/104 Kataganj Po – Bedi Bhaban, Nadia, West Bengal, India – 741250.
As per the financials filed for FY 2024, the company reported a revenue of ₹72.66 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1 Lakh (net margin 1.4%) and EBITDA of ₹2.34 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 70% over three years.
The company has about 14 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹23.13 Lakh on record.
Sloventis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-15-0003439).
Company details
CIN U24290WB2020PTC237341
Registration Number 237341
Incorporation Date 05 June 2020
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-WB-15-0003439
Recognitions & Rankings of Sloventis Pharma
Contact details
Sloventis Pharma Private Limited's registered office is in Nadia, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.4/104 Kataganj Po – Bedi Bhaban, Nadia, West Bengal, India – 741250
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sloventis Pharma Private Limited, buy the company report.
Comprehensive company report
Sloventis Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sloventis Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sloventis Pharma Private Limited, buy the company report.
Financials of Sloventis Pharma Private Limited
FY 2025 filings availableSloventis Pharma Private Limited reported revenue of ₹72.66 Lakh (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹72.66 Lakh ▲ 11%
Net profit · FY 2024
₹1 Lakh margin 1.4%
EBITDA · FY 2024
₹2.34 Lakh margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 70%
EBITDA CAGR growth
1 year
▲ 64%
3 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 70% over three years, including 11% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.34 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.2% | |||
| Net Profit Margin | 1.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sloventis Pharma Private Limited, buy the company report.
Board of directors of Sloventis Pharma Private Limited
Sloventis Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhasmita Panda | Director | 05 Jun 2020 | 6 Years 4 Months | Current |
| Anil Kumar Panda Also directs: Granvia Healthcare Private Limited | Director | 23 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Sloventis Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pci Bioscience Private Limited | ₹73.08 Lakh (FY 2024) | -14.0% | Mandi Adampur, Haryana, India | |||
| Caraway Pharma Private Limited | ₹72.97 Lakh (FY 2021) | -54.0% | Madurai, Tamil Nadu, India | |||
| Nectar Healthscience Private Limited | ₹72.96 Lakh (FY 2025) | 118.0% | Agra, Uttar Pradesh, India | |||
| Advitam Life Sciences Private Limited | ₹72.9 Lakh (FY 2022) | 27.0% | New Delhi, Delhi, India | |||
| Sloventis Pharma Private Limitedthis company | ₹72.66 Lakh (FY 2024) | ₹1 Lakh | 1.4% | 11.0% | 14 | Nadia, West Bengal, India |
| Icon Lifecare Private Limited | ₹72.54 Lakh (FY 2024) | 21.0% | Hathras, Uttar Pradesh, India | |||
| Studdmed Healthcare Private Limited | ₹72.53 Lakh (FY 2025) | 90.0% | Tarapur, Assam, India |
To see the full peer comparison of Sloventis Pharma Private Limited, buy the company report.
Auditor
Sloventis Pharma Private Limited is audited by R.C.PRADHAN&COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.C.PRADHAN&COMPANY | FY 2023 | 325584E |
Shareholding
The shareholding of Sloventis Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sloventis Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹23.13 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 May 2025 | 101104692 | State Bank of India | ₹23.13 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sloventis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sloventis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sloventis Pharma Private Limited has a workforce of 14 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
14
Active EPFO establishments
1
Employee growth
7.69%
GST
Sloventis Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21ABDCS7312J1ZJ | Odisha | Active | 17 Jul 2020 |
To see the full GST registrations and return filing status of Sloventis Pharma Private Limited, buy the company report.
Recent activity
Sloventis Pharma Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Rama Kanta Parihari ceased to be Director on 13 Jan 2025.
AGM
Sloventis Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 23.13 Lakh with Charge ID 101104692 was registered on 23 May 2025.
Filing
Sloventis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Ceased
Rama Kanta Parihari ceased to be Director.
Appointed
Anil Kumar Panda was appointed as Director.
Ceased
Sandhya Ray ceased to be Director.
Appointed
Rama Kanta Parihari was appointed as Director.
Appointed
Sandhya Ray was appointed as Director.
Appointed
Subhasmita Panda was appointed as Director.
Incorporation
05 Jun 2020
Sloventis Pharma Private Limited was registered on 05 Jun 2020 with Roc Kolkata & aged 6 years 4 months as per MCA records.
Frequently asked questions
Sloventis Pharma is an active private limited company based in Nadia, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 June 2020 (6+ years old) and is registered under CIN U24290WB2020PTC237341.
Sloventis Pharma has 2 current directors:
- Subhasmita Panda - Director
- Anil Kumar Panda - Director
The latest financial statements of Sloventis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Sloventis Pharma is 21ABDCS7312J1ZJ, registered in Odisha.
The CIN (Corporate Identification Number) of Sloventis Pharma is U24290WB2020PTC237341. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sloventis Pharma was incorporated on 05 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Sloventis Pharma by revenue are Pci Bioscience Private Limited, Caraway Pharma Private Limited, Nectar Healthscience Private Limited, Advitam Life Sciences Private Limited, Icon Lifecare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rama Kanta Parihari ceased to be Director on 13 Jan 2025. Anil Kumar Panda was appointed as Director on 23 Aug 2024. Sandhya Ray ceased to be Director on 23 Aug 2024. Sloventis Pharma has 6 board changes on record in total.
Yes, Sloventis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-15-0003439).
The registered office of Sloventis Pharma is at Plot No.4104 Kataganj Po – Bedi Bhaban, Nadia, West Bengal, India – 741250.
Sloventis Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages